Brendan Teehan
Chief Operating Officer bei ACADIA PHARMACEUTICALS INC.
Vermögen: 717 338 $ am 31.03.2024
Profil
Brendan P.
Teehan is currently the Chief Operating Officer, EVP & Head-Commercial at ACADIA Pharmaceuticals, Inc. He previously worked as the Vice President-Building & Provider Solutions at Tesaro, Inc. from 2016 to 2018, and as the Senior Vice President & Vice President at RT Oncology Services Corp.
from 2012 to 2016.
Mr. Teehan holds an MBA degree from Carnegie Mellon University and an undergraduate degree from the University of Notre Dame, which he received in 1990.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.04.2024 | 38 796 ( 0,02% ) | 717 338 $ | 31.03.2024 |
Aktive Positionen von Brendan Teehan
| Unternehmen | Position | Beginn |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Chief Operating Officer | 01.11.2021 |
Ehemalige bekannte Positionen von Brendan Teehan
| Unternehmen | Position | Ende |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 01.07.2018 |
RT Oncology Services Corp.
 RT Oncology Services Corp. Miscellaneous Commercial ServicesCommercial Services RT Oncology Services Corp. is a holding company, which engages in the provision of oncology related assistance services. It assists its member practices in achieving better and more cost effective treatment of oncology patients while creating new streams of revenue for community oncology practices. The company was founded by Michael J. Martin, John Creelman, and Jeffrey Patton in 2011 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.04.2016 |
Ausbildung von Brendan Teehan
| Carnegie Mellon University | Masters Business Admin |
| University of Notre Dame | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
RT Oncology Services Corp.
RT Oncology Services Corp. Miscellaneous Commercial ServicesCommercial Services RT Oncology Services Corp. is a holding company, which engages in the provision of oncology related assistance services. It assists its member practices in achieving better and more cost effective treatment of oncology patients while creating new streams of revenue for community oncology practices. The company was founded by Michael J. Martin, John Creelman, and Jeffrey Patton in 2011 and is headquartered in San Diego, CA. | Commercial Services |
